Derosu Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2422 since 2018-10-01 the company is, as the updated on 2020-03-04 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2000-07-01 until 2019-12-31. Known company numbers for Derosu Pty Ltd are as follows: ACN - 003413018, Australian Business Number - 90003413018. Jeff Love is one of the trading names this company has used, to be precise, the trading names list includes 1 position that is Jeff Love since 2000-03-28. This company had suspended their activity from 2019-12-31 to 2019-12-31. This Australian proprietary company was previously located in NSW 2257 (from 2016-02-03 to 2018-10-01), NSW 2077 (from 2014-09-21 to 2016-02-03), NSW 2077 (from 2014-01-10 to 2014-09-21).
Status | From | To |
---|---|---|
Cancelled | December 31, 2019 | current |
Active | November 1, 1999 | December 31, 2019 |
Name | From | To |
---|---|---|
Derosu Pty Ltd | November 1, 1999 | current |
Name | From | To |
---|---|---|
Jeff Love | March 28, 2000 | current |
Location | From | To |
---|---|---|
NSW 2422 | October 1, 2018 | current |
NSW 2257 | February 3, 2016 | October 1, 2018 |
NSW 2077 | September 21, 2014 | February 3, 2016 |
NSW 2077 | January 10, 2014 | September 21, 2014 |
NSW 2077 | March 28, 2000 | January 10, 2014 |
Status | From | To |
---|---|---|
Registered | July 1, 2000 | December 31, 2019 |
Advertisements
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.